{"entity":{"type":"insider","cik":"0001398330","url":"/insider/0001398330","json_url":"/insider/0001398330.json","name":"SCP Vitalife Partners II LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":48,"n_filings":26,"first":"2015-11-25","last":"2020-12-28","span_basis":"filed_date"},"name_variants":[{"name":"SCP Vitalife Partners II LP","source":"filing","n_filings":26,"first_seen":"2015-11-25","last_seen":"2020-12-28"}],"transactions":[{"id":2311805,"accession":"0001192482-20-000849","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-20-000849","line_url":"/filing/0001192482-20-000849#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56375.0,"shares_display":"56,375","price_per_share":3.17,"price_display":"3.17","price_state":"stated","total_value":178708.75,"total_display":"178,708.75","total_whole":"178,709","shares_owned_after":2097938.0,"shares_owned_after_display":"2,097,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-22","filed_date":"2020-12-28","scope":"insider"},{"id":2411912,"accession":"0001192482-20-000845","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-20-000845","line_url":"/filing/0001192482-20-000845#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18587.0,"shares_display":"18,587","price_per_share":3.0304,"price_display":"3.03","price_state":"stated","total_value":56326.0448,"total_display":"56,326.04","total_whole":"56,326","shares_owned_after":2154313.0,"shares_owned_after_display":"2,154,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider"},{"id":6413520,"accession":"0001192482-18-000031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-18-000031","line_url":"/filing/0001192482-18-000031#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4732.0,"shares_display":"4,732","price_per_share":8.8382,"price_display":"8.84","price_state":"stated","total_value":41822.3624,"total_display":"41,822.36","total_whole":"41,822","shares_owned_after":2172900.0,"shares_owned_after_display":"2,172,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-04","filed_date":"2018-01-08","scope":"insider"},{"id":6815841,"accession":"0001192482-18-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-18-000011","line_url":"/filing/0001192482-18-000011#line-2","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19863.0,"shares_display":"19,863","price_per_share":8.733,"price_display":"8.73","price_state":"stated","total_value":173463.579,"total_display":"173,463.58","total_whole":"173,464","shares_owned_after":2177632.0,"shares_owned_after_display":"2,177,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-03","filed_date":"2018-01-04","scope":"insider"},{"id":6815834,"accession":"0001192482-18-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-18-000011","line_url":"/filing/0001192482-18-000011#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18947.0,"shares_display":"18,947","price_per_share":9.037,"price_display":"9.04","price_state":"stated","total_value":171224.039,"total_display":"171,224.04","total_whole":"171,224","shares_owned_after":2197495.0,"shares_owned_after_display":"2,197,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"},{"id":6894746,"accession":"0001192482-18-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-18-000001","line_url":"/filing/0001192482-18-000001#line-2","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12305.0,"shares_display":"12,305","price_per_share":9.1948,"price_display":"9.19","price_state":"stated","total_value":113142.014,"total_display":"113,142.01","total_whole":"113,142","shares_owned_after":2216442.0,"shares_owned_after_display":"2,216,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-29","filed_date":"2018-01-02","scope":"insider"},{"id":6894742,"accession":"0001192482-18-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-18-000001","line_url":"/filing/0001192482-18-000001#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5926.0,"shares_display":"5,926","price_per_share":9.4395,"price_display":"9.44","price_state":"stated","total_value":55938.477,"total_display":"55,938.48","total_whole":"55,938","shares_owned_after":2228747.0,"shares_owned_after_display":"2,228,747","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-28","filed_date":"2018-01-02","scope":"insider"},{"id":4474835,"accession":"0001192482-17-000328","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-17-000328","line_url":"/filing/0001192482-17-000328#line-2","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8391.0,"shares_display":"8,391","price_per_share":9.5388,"price_display":"9.54","price_state":"stated","total_value":80040.0708,"total_display":"80,040.07","total_whole":"80,040","shares_owned_after":2234673.0,"shares_owned_after_display":"2,234,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-27","filed_date":"2017-12-28","scope":"insider"},{"id":4474830,"accession":"0001192482-17-000328","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-17-000328","line_url":"/filing/0001192482-17-000328#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4798.0,"shares_display":"4,798","price_per_share":9.5906,"price_display":"9.59","price_state":"stated","total_value":46015.6988,"total_display":"46,015.70","total_whole":"46,016","shares_owned_after":2243064.0,"shares_owned_after_display":"2,243,064","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-26","filed_date":"2017-12-28","scope":"insider"},{"id":4673765,"accession":"0001144204-17-034631","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-034631","line_url":"/filing/0001144204-17-034631#line-2","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife II Associates, L.P.; SCP Vitalife Partners II LP; SCP Vitalife II GP, Ltd.; LUDOMIRSKI ABRAHAM; CHURCHILL WINSTON J","owner_display_name":"SCP Vitalife II Associates, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37459.0,"shares_display":"37,459","price_per_share":3.0931,"price_display":"3.09","price_state":"stated","total_value":115864.4329,"total_display":"115,864.43","total_whole":"115,864","shares_owned_after":1017674.0,"shares_owned_after_display":"1,017,674","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-27","filed_date":"2017-06-28","scope":"insider"},{"id":4673762,"accession":"0001144204-17-034631","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-034631","line_url":"/filing/0001144204-17-034631#line-1","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife II Associates, L.P.; SCP Vitalife Partners II LP; SCP Vitalife II GP, Ltd.; LUDOMIRSKI ABRAHAM; CHURCHILL WINSTON J","owner_display_name":"SCP Vitalife II Associates, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27759.0,"shares_display":"27,759","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":83277.0,"total_display":"83,277.00","total_whole":"83,277","shares_owned_after":1055133.0,"shares_owned_after_display":"1,055,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-26","filed_date":"2017-06-28","scope":"insider"},{"id":9225526,"accession":"0001123292-17-000718","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001123292-17-000718","line_url":"/filing/0001123292-17-000718#line-3","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9488.0,"shares_display":"9,488","price_per_share":7.9258,"price_display":"7.93","price_state":"stated","total_value":75199.9904,"total_display":"75,199.99","total_whole":"75,200","shares_owned_after":2247862.0,"shares_owned_after_display":"2,247,862","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-16","filed_date":"2017-03-20","scope":"insider"},{"id":5130181,"accession":"0001123292-17-000693","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001123292-17-000693","line_url":"/filing/0001123292-17-000693#line-3","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9488.0,"shares_display":"9,488","price_per_share":7.9258,"price_display":"7.93","price_state":"stated","total_value":75199.9904,"total_display":"75,199.99","total_whole":"75,200","shares_owned_after":2247922.0,"shares_owned_after_display":"2,247,922","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-16","filed_date":"2017-03-16","scope":"insider"},{"id":9225525,"accession":"0001123292-17-000718","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001123292-17-000718","line_url":"/filing/0001123292-17-000718#line-2","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19161.0,"shares_display":"19,161","price_per_share":8.0122,"price_display":"8.01","price_state":"stated","total_value":153521.7642,"total_display":"153,521.76","total_whole":"153,522","shares_owned_after":2257350.0,"shares_owned_after_display":"2,257,350","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-15","filed_date":"2017-03-20","scope":"insider"},{"id":5130174,"accession":"0001123292-17-000693","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001123292-17-000693","line_url":"/filing/0001123292-17-000693#line-2","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19161.0,"shares_display":"19,161","price_per_share":8.0122,"price_display":"8.01","price_state":"stated","total_value":153521.7642,"total_display":"153,521.76","total_whole":"153,522","shares_owned_after":2257410.0,"shares_owned_after_display":"2,257,410","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-15","filed_date":"2017-03-16","scope":"insider"},{"id":9225527,"accession":"0001123292-17-000718","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-17-000718","line_url":"/filing/0001123292-17-000718#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16328.0,"shares_display":"16,328","price_per_share":8.0396,"price_display":"8.04","price_state":"stated","total_value":131270.5888,"total_display":"131,270.59","total_whole":"131,271","shares_owned_after":2276511.0,"shares_owned_after_display":"2,276,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-14","filed_date":"2017-03-20","scope":"insider"},{"id":5130168,"accession":"0001123292-17-000693","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-17-000693","line_url":"/filing/0001123292-17-000693#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16328.0,"shares_display":"16,328","price_per_share":8.0396,"price_display":"8.04","price_state":"stated","total_value":131270.5888,"total_display":"131,270.59","total_whole":"131,271","shares_owned_after":2276571.0,"shares_owned_after_display":"2,276,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-14","filed_date":"2017-03-16","scope":"insider"},{"id":9225528,"accession":"0001123292-17-000719","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-17-000719","line_url":"/filing/0001123292-17-000719#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9983.0,"shares_display":"9,983","price_per_share":7.592,"price_display":"7.59","price_state":"stated","total_value":75790.936,"total_display":"75,790.94","total_whole":"75,791","shares_owned_after":2292839.0,"shares_owned_after_display":"2,292,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-17","filed_date":"2017-03-20","scope":"insider"},{"id":4303221,"accession":"0001123292-17-000451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-17-000451","line_url":"/filing/0001123292-17-000451#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9983.0,"shares_display":"9,983","price_per_share":7.592,"price_display":"7.59","price_state":"stated","total_value":75790.936,"total_display":"75,790.94","total_whole":"75,791","shares_owned_after":2292899.0,"shares_owned_after_display":"2,292,899","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-17","filed_date":"2017-02-21","scope":"insider"},{"id":9225524,"accession":"0001123292-17-000717","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001123292-17-000717","line_url":"/filing/0001123292-17-000717#line-3","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3293.0,"shares_display":"3,293","price_per_share":7.8572,"price_display":"7.86","price_state":"stated","total_value":25873.7596,"total_display":"25,873.76","total_whole":"25,874","shares_owned_after":2302822.0,"shares_owned_after_display":"2,302,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-03-20","scope":"insider"},{"id":4112264,"accession":"0001123292-17-000446","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001123292-17-000446","line_url":"/filing/0001123292-17-000446#line-3","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3293.0,"shares_display":"3,293","price_per_share":7.8572,"price_display":"7.86","price_state":"stated","total_value":25873.7596,"total_display":"25,873.76","total_whole":"25,874","shares_owned_after":2302882.0,"shares_owned_after_display":"2,302,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-02-17","scope":"insider"},{"id":9225523,"accession":"0001123292-17-000717","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001123292-17-000717","line_url":"/filing/0001123292-17-000717#line-2","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6479.0,"shares_display":"6,479","price_per_share":7.88,"price_display":"7.88","price_state":"stated","total_value":51054.52,"total_display":"51,054.52","total_whole":"51,055","shares_owned_after":2306115.0,"shares_owned_after_display":"2,306,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-15","filed_date":"2017-03-20","scope":"insider"},{"id":4112261,"accession":"0001123292-17-000446","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001123292-17-000446","line_url":"/filing/0001123292-17-000446#line-2","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6479.0,"shares_display":"6,479","price_per_share":7.88,"price_display":"7.88","price_state":"stated","total_value":51054.52,"total_display":"51,054.52","total_whole":"51,055","shares_owned_after":2306115.0,"shares_owned_after_display":"2,306,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-15","filed_date":"2017-02-17","scope":"insider"},{"id":9225522,"accession":"0001123292-17-000717","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-17-000717","line_url":"/filing/0001123292-17-000717#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2293.0,"shares_display":"2,293","price_per_share":7.9559,"price_display":"7.96","price_state":"stated","total_value":18242.8787,"total_display":"18,242.88","total_whole":"18,243","shares_owned_after":2312594.0,"shares_owned_after_display":"2,312,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-14","filed_date":"2017-03-20","scope":"insider"},{"id":4112257,"accession":"0001123292-17-000446","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-17-000446","line_url":"/filing/0001123292-17-000446#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2293.0,"shares_display":"2,293","price_per_share":7.9559,"price_display":"7.96","price_state":"stated","total_value":18242.8787,"total_display":"18,242.88","total_whole":"18,243","shares_owned_after":2312594.0,"shares_owned_after_display":"2,312,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-14","filed_date":"2017-02-17","scope":"insider"},{"id":4490072,"accession":"0001123292-17-000427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-17-000427","line_url":"/filing/0001123292-17-000427#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7937.0,"shares_display":"7,937","price_per_share":7.9704,"price_display":"7.97","price_state":"stated","total_value":63261.0648,"total_display":"63,261.06","total_whole":"63,261","shares_owned_after":2314887.0,"shares_owned_after_display":"2,314,887","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-13","filed_date":"2017-02-15","scope":"insider"},{"id":3284611,"accession":"0001144204-16-120034","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001144204-16-120034","line_url":"/filing/0001144204-16-120034","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"CHURCHILL WINSTON J; LUDOMIRSKI ABRAHAM; SCP Vitalife Partners II LP; SCP Vitalife II Associates, L.P.","owner_display_name":"CHURCHILL WINSTON J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42155.0,"shares_display":"42,155","price_per_share":6.306425247301625,"price_display":"6.31","price_state":"stated","total_value":265847.3563,"total_display":"265,847.36","total_whole":"265,847","shares_owned_after":1082892.0,"shares_owned_after_display":"1,082,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-16","filed_date":"2016-08-17","scope":"insider","n_lines":2},{"id":3284604,"accession":"0001144204-16-120034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-120034","line_url":"/filing/0001144204-16-120034#line-1","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"CHURCHILL WINSTON J; LUDOMIRSKI ABRAHAM; SCP Vitalife Partners II LP; SCP Vitalife II Associates, L.P.","owner_display_name":"CHURCHILL WINSTON J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32807.0,"shares_display":"32,807","price_per_share":6.4483,"price_display":"6.45","price_state":"stated","total_value":211549.3781,"total_display":"211,549.38","total_whole":"211,549","shares_owned_after":1125047.0,"shares_owned_after_display":"1,125,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-15","filed_date":"2016-08-17","scope":"insider"},{"id":2089114,"accession":"0001144204-16-107111","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-107111","line_url":"/filing/0001144204-16-107111#line-2","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife Partners II LP; SCP Vitalife II Associates, L.P.; SCP Vitalife II GP, Ltd.; LUDOMIRSKI ABRAHAM; CHURCHILL WINSTON J","owner_display_name":"SCP Vitalife Partners II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3965.0,"shares_display":"3,965","price_per_share":7.8961,"price_display":"7.90","price_state":"stated","total_value":31308.0365,"total_display":"31,308.04","total_whole":"31,308","shares_owned_after":1157854.0,"shares_owned_after_display":"1,157,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-03","filed_date":"2016-06-06","scope":"insider"},{"id":2089080,"accession":"0001144204-16-107111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-107111","line_url":"/filing/0001144204-16-107111#line-1","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"SCP Vitalife Partners II LP; SCP Vitalife II Associates, L.P.; SCP Vitalife II GP, Ltd.; LUDOMIRSKI ABRAHAM; CHURCHILL WINSTON J","owner_display_name":"SCP Vitalife Partners II LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10323.0,"shares_display":"10,323","price_per_share":7.8911,"price_display":"7.89","price_state":"stated","total_value":81459.8253,"total_display":"81,459.83","total_whole":"81,460","shares_owned_after":1161819.0,"shares_owned_after_display":"1,161,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-02","filed_date":"2016-06-06","scope":"insider"},{"id":2844572,"accession":"0001144204-16-106510","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-106510","line_url":"/filing/0001144204-16-106510#line-2","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"CHURCHILL WINSTON J; SCP Vitalife II GP, Ltd.; LUDOMIRSKI ABRAHAM; SCP Vitalife Partners II LP; SCP Vitalife II Associates, L.P.","owner_display_name":"CHURCHILL WINSTON J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4700.0,"shares_display":"4,700","price_per_share":7.5788,"price_display":"7.58","price_state":"stated","total_value":35620.36,"total_display":"35,620.36","total_whole":"35,620","shares_owned_after":1172142.0,"shares_owned_after_display":"1,172,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-01","filed_date":"2016-06-02","scope":"insider"},{"id":2844569,"accession":"0001144204-16-106510","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-106510","line_url":"/filing/0001144204-16-106510#line-1","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"CHURCHILL WINSTON J; SCP Vitalife II GP, Ltd.; LUDOMIRSKI ABRAHAM; SCP Vitalife Partners II LP; SCP Vitalife II Associates, L.P.","owner_display_name":"CHURCHILL WINSTON J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3823.0,"shares_display":"3,823","price_per_share":7.941,"price_display":"7.94","price_state":"stated","total_value":30358.443,"total_display":"30,358.44","total_whole":"30,358","shares_owned_after":1176842.0,"shares_owned_after_display":"1,176,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-31","filed_date":"2016-06-02","scope":"insider"},{"id":2333268,"accession":"0001144204-16-105622","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-105622","line_url":"/filing/0001144204-16-105622#line-2","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"CHURCHILL WINSTON J; LUDOMIRSKI ABRAHAM; SCP Vitalife Partners II LP; SCP Vitalife II Associates, L.P.; SCP Vitalife II GP, Ltd.","owner_display_name":"CHURCHILL WINSTON J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11244.0,"shares_display":"11,244","price_per_share":8.6071,"price_display":"8.61","price_state":"stated","total_value":96778.2324,"total_display":"96,778.23","total_whole":"96,778","shares_owned_after":1180665.0,"shares_owned_after_display":"1,180,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-26","filed_date":"2016-05-27","scope":"insider"},{"id":2333264,"accession":"0001144204-16-105622","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-105622","line_url":"/filing/0001144204-16-105622#line-1","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"CHURCHILL WINSTON J; LUDOMIRSKI ABRAHAM; SCP Vitalife Partners II LP; SCP Vitalife II Associates, L.P.; SCP Vitalife II GP, Ltd.","owner_display_name":"CHURCHILL WINSTON J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9012.0,"shares_display":"9,012","price_per_share":8.7972,"price_display":"8.80","price_state":"stated","total_value":79280.3664,"total_display":"79,280.37","total_whole":"79,280","shares_owned_after":1191909.0,"shares_owned_after_display":"1,191,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-25","filed_date":"2016-05-27","scope":"insider"},{"id":2477487,"accession":"0001144204-16-104906","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-104906","line_url":"/filing/0001144204-16-104906#line-2","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"LUDOMIRSKI ABRAHAM; SCP Vitalife Partners II LP; CHURCHILL WINSTON J; SCP Vitalife II Associates, L.P.; SCP Vitalife II GP, Ltd.","owner_display_name":"LUDOMIRSKI ABRAHAM","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150.0,"shares_display":"150","price_per_share":8.95,"price_display":"8.95","price_state":"stated","total_value":1342.5,"total_display":"1,342.50","total_whole":"1,343","shares_owned_after":1200921.0,"shares_owned_after_display":"1,200,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-24","filed_date":"2016-05-25","scope":"insider"},{"id":3163049,"accession":"0001123292-16-002339","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-16-002339","line_url":"/filing/0001123292-16-002339#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7497.0,"shares_display":"7,497","price_per_share":6.3001,"price_display":"6.30","price_state":"stated","total_value":47231.8497,"total_display":"47,231.85","total_whole":"47,232","shares_owned_after":2322824.0,"shares_owned_after_display":"2,322,824","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-25","scope":"insider"},{"id":2477484,"accession":"0001144204-16-104906","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-104906","line_url":"/filing/0001144204-16-104906#line-1","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"LUDOMIRSKI ABRAHAM; SCP Vitalife Partners II LP; CHURCHILL WINSTON J; SCP Vitalife II Associates, L.P.; SCP Vitalife II GP, Ltd.","owner_display_name":"LUDOMIRSKI ABRAHAM","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":8100.0,"total_display":"8,100.00","total_whole":"8,100","shares_owned_after":1201071.0,"shares_owned_after_display":"1,201,071","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-25","scope":"insider"},{"id":2844564,"accession":"0001144204-16-104290","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-16-104290","line_url":"/filing/0001144204-16-104290#line-2","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"CHURCHILL WINSTON J; SCP Vitalife II GP, Ltd.; LUDOMIRSKI ABRAHAM; SCP Vitalife II Associates, L.P.; SCP Vitalife Partners II LP","owner_display_name":"CHURCHILL WINSTON J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8357.0,"shares_display":"8,357","price_per_share":9.0788,"price_display":"9.08","price_state":"stated","total_value":75871.5316,"total_display":"75,871.53","total_whole":"75,872","shares_owned_after":1201971.0,"shares_owned_after_display":"1,201,971","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-20","filed_date":"2016-05-23","scope":"insider"},{"id":2320203,"accession":"0001123292-16-002313","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001123292-16-002313","line_url":"/filing/0001123292-16-002313#line-2","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14992.0,"shares_display":"14,992","price_per_share":6.4548,"price_display":"6.45","price_state":"stated","total_value":96770.3616,"total_display":"96,770.36","total_whole":"96,770","shares_owned_after":2330321.0,"shares_owned_after_display":"2,330,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-20","filed_date":"2016-05-23","scope":"insider"},{"id":2844560,"accession":"0001144204-16-104290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-104290","line_url":"/filing/0001144204-16-104290#line-1","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"CHURCHILL WINSTON J; SCP Vitalife II GP, Ltd.; LUDOMIRSKI ABRAHAM; SCP Vitalife II Associates, L.P.; SCP Vitalife Partners II LP","owner_display_name":"CHURCHILL WINSTON J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3748.0,"shares_display":"3,748","price_per_share":9.119,"price_display":"9.12","price_state":"stated","total_value":34178.012,"total_display":"34,178.01","total_whole":"34,178","shares_owned_after":1210328.0,"shares_owned_after_display":"1,210,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-19","filed_date":"2016-05-23","scope":"insider"},{"id":2320201,"accession":"0001123292-16-002313","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-16-002313","line_url":"/filing/0001123292-16-002313#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3748.0,"shares_display":"3,748","price_per_share":6.4559,"price_display":"6.46","price_state":"stated","total_value":24196.7132,"total_display":"24,196.71","total_whole":"24,197","shares_owned_after":2345313.0,"shares_owned_after_display":"2,345,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-19","filed_date":"2016-05-23","scope":"insider"},{"id":2609847,"accession":"0001144204-16-076259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-16-076259","line_url":"/filing/0001144204-16-076259#line-1","is_derivative":false,"issuer_cik":"0000923792","issuer_name":"ReWalk Robotics Ltd.","issuer_ticker":"RWLK","issuer_name_source":null,"issuer_url":"/issuer/0000923792","owner_cik":null,"owner_name":"CHURCHILL WINSTON J; SCP Vitalife II GP, Ltd.; SCP Vitalife Partners II LP; SCP Vitalife II Associates, L.P.","owner_display_name":"CHURCHILL WINSTON J","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Ordinary Shares, par value NIS 0.01 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37481.0,"shares_display":"37,481","price_per_share":10.2968,"price_display":"10.30","price_state":"stated","total_value":385934.3608,"total_display":"385,934.36","total_whole":"385,934","shares_owned_after":1214076.0,"shares_owned_after_display":"1,214,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-15","filed_date":"2016-01-20","scope":"insider"},{"id":8633368,"accession":"0001192482-15-000431","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-15-000431","line_url":"/filing/0001192482-15-000431#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":450.0,"shares_display":"450","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":4050.0,"total_display":"4,050.00","total_whole":"4,050","shares_owned_after":2349061.0,"shares_owned_after_display":"2,349,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-30","filed_date":"2015-12-01","scope":"insider"},{"id":8917447,"accession":"0001192482-15-000428","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-15-000428","line_url":"/filing/0001192482-15-000428#line-2","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6737.0,"shares_display":"6,737","price_per_share":9.0009,"price_display":"9.00","price_state":"stated","total_value":60639.0633,"total_display":"60,639.06","total_whole":"60,639","shares_owned_after":2349511.0,"shares_owned_after_display":"2,349,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-27","filed_date":"2015-11-30","scope":"insider"},{"id":8917444,"accession":"0001192482-15-000428","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-15-000428","line_url":"/filing/0001192482-15-000428#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4648.0,"shares_display":"4,648","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":41832.0,"total_display":"41,832.00","total_whole":"41,832","shares_owned_after":2356248.0,"shares_owned_after_display":"2,356,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-25","filed_date":"2015-11-30","scope":"insider"},{"id":8659522,"accession":"0001192482-15-000427","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-15-000427","line_url":"/filing/0001192482-15-000427#line-2","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2068.0,"shares_display":"2,068","price_per_share":9.006,"price_display":"9.01","price_state":"stated","total_value":18624.408,"total_display":"18,624.41","total_whole":"18,624","shares_owned_after":2360896.0,"shares_owned_after_display":"2,360,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-24","filed_date":"2015-11-25","scope":"insider"},{"id":8659518,"accession":"0001192482-15-000427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-15-000427","line_url":"/filing/0001192482-15-000427#line-1","is_derivative":false,"issuer_cik":"0001398330","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001398330","owner_cik":"0001398330","owner_name":"SCP Vitalife Partners II LP","owner_display_name":"SCP Vitalife Partners II LP","owner_url":"/insider/0001398330","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11082.0,"shares_display":"11,082","price_per_share":9.0009,"price_display":"9.00","price_state":"stated","total_value":99747.9738,"total_display":"99,747.97","total_whole":"99,748","shares_owned_after":2362964.0,"shares_owned_after_display":"2,362,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-23","filed_date":"2015-11-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001588972","name":"Recro Pharma, Inc.","url":"/issuer/0001588972","role":"Ten percent owner","n_filings":18,"first_seen":"2015-11-25","last_seen":"2020-12-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001607962","name":"ReWalk Robotics Ltd.","url":"/issuer/0001607962","role":"Ten percent owner","n_filings":8,"first_seen":"2016-01-20","last_seen":"2017-06-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001398330","retrieved_at":"2026-08-24T16:10:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}